General Practice Doctors in Bloomington, IN Accepting Medicare

4 General Practice doctors found. Showing 1 - 4

Dr. James M Sullivan, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1000 W 1st St, Bloomington, IN 47403 Phone: 812-333-4327    Fax: 812-961-1521

Dr. David Rudolf Fletcher, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 126 S. Hampton Ct, Bloomington, IN 47408 Phone: 812-322-5779

Mr. Michael Francis Kenrick, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1421 Cedar Bluff Road, Bloomington, IN 47403 Phone: 812-824-1642

Sarah Ryterband, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 820 W 2nd St, Bloomington, IN 47403 Phone: 812-333-9139

News Archive

ZymoGenetics' IL-21 Phase 2 clinical trial in metastatic melanoma meets primary endpoint

ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

Anacardic acid can rescue some ALS phenotypes in vitro

A research group at the Center for iPS Cell Research and Application (CiRA) at Japan's Kyoto University has successfully recapitulated amyotrophic lateral sclerosis (ALS)-associated abnormalities in motor neurons differentiated from induced pluripotent stem cells (iPSCs) obtained from patients with familial ALS, a late-onset, fatal disorder which is also known for Lou Gehrig's disease. In a drug screening assay using the disease model, the team further found that the chemical compound anacardic acid can rescue some ALS phenotypes in vitro.

Inpeco, Precise Biometrics partner to deploy Precise Match-on-Card technology

Precise Biometrics announces today that they have partnered with the Inpeco Group for a 6-month contract, to deploy Precise Match-on-Card technology to the Inpeco Group System.

Del Global Technologies files registration statement with SEC for rights offering

Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.

Read more Medical News

› Verified 1 days ago